These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102. ON SPECIFIC ANTITOXINS IN STREPTOCOCCAL INFECTIONS. Brown HH Br Med J; 1930 Jun; 1(3623):1092-3. PubMed ID: 20775508 [No Abstract] [Full Text] [Related]
103. Clindamycin resistance in Group A streptococcal infections: A single-centre retrospective cohort study of 186 patients. Salle R; Chosidow O; Fihman V; de Prost N; Zeghbib N; Woerther PL; Hua C J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):e888-e889. PubMed ID: 36800305 [No Abstract] [Full Text] [Related]
105. Comment on Fox et al's presentation of two invasive group A streptococcal (GAS) infections. Mulla ZD J Emerg Med; 2003 May; 24(4):473-4. PubMed ID: 12745058 [No Abstract] [Full Text] [Related]
106. [Toxic shock-like syndrome caused by streptococci--treated with clindamycin]. Nørgaard M Ugeskr Laeger; 1997 Apr; 159(16):2396-7. PubMed ID: 9163118 [TBL] [Abstract][Full Text] [Related]
107. Editorial commentary: step on the GAS: are we almost there for clindamycin and intravenous immunoglobulin? Tan LK; Sriskandan S Clin Infect Dis; 2014 Aug; 59(3):366-8. PubMed ID: 24785238 [No Abstract] [Full Text] [Related]
108. [Does the antitoxin activity of clindamycin decrease mortality in invasive streptococcal infections?]. Ferry T Med Mal Infect; 2015 May; 45(5):185-6. PubMed ID: 26153577 [No Abstract] [Full Text] [Related]
109. [Streptococcus pyogenes an emerging pathogen]. Cohen R; Aujard Y; Bidet P; Bourrillon A; Bingen E; Foucaud P; François M; Garnier JM; Gendrel D; Guillot M; Hau I; Olivier C; Quinet B; Raymond J Arch Pediatr; 2005 Jul; 12(7):1065-7. PubMed ID: 15913971 [No Abstract] [Full Text] [Related]
110. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. Babiker A; Li X; Lai YL; Strich JR; Warner S; Sarzynski S; Dekker JP; Danner RL; Kadri SS Lancet Infect Dis; 2021 May; 21(5):697-710. PubMed ID: 33333013 [TBL] [Abstract][Full Text] [Related]
111. Alternatives to penicillin in the management of group A streptococcal pharyngitis. Gooch WM Pediatr Ann; 1992 Dec; 21(12):810-5. PubMed ID: 1480434 [No Abstract] [Full Text] [Related]
112. [Toxic shock-like syndrome caused by streptococci]. van Dissel JT; Kullberg BJ; van der Meer JW Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1452-5. PubMed ID: 10443259 [TBL] [Abstract][Full Text] [Related]
113. Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndromes. Russell NE; Pachorek RE Ann Pharmacother; 2000; 34(7-8):936-9. PubMed ID: 10928407 [TBL] [Abstract][Full Text] [Related]
114. [Beta-hemolytic streptococcal bacteremia in adults]. Rantala S Duodecim; 2013; 129(14):1477-84. PubMed ID: 23961606 [TBL] [Abstract][Full Text] [Related]